CSTONE PHARMACEUTICALS revenue breakdown overview

CSTONE PHARMACEUTICALS revenue for the last year amounted to 433.41 M HKD, the most of which — 512.54 M HKD — came from its highest performing source at the moment, Biopharmaceutical Products, the year earlier bringing 559.77 M HKD. The greatest contribution to the revenue figure was made by China (excluding Hong Kong and Taiwan) — last year it brought CSTONE PHARMACEUTICALS 409.11 M HKD, and the year before that — 554.14 M HKD.